relapsing-remitting multiple sclerosis

Summary

relapsing-remitting multiple sclerosis is a class of disease^[1].

Key Facts

• relapsing-remitting multiple sclerosis's instance of is recorded as class of disease^[2].
• relapsing-remitting multiple sclerosis's subclass of is recorded as multiple sclerosis^[3].
• relapsing-remitting multiple sclerosis's MeSH descriptor ID is recorded as D020529^[4].
• relapsing-remitting multiple sclerosis's MeSH tree code is recorded as C10.114.375.500.600^[5].
• relapsing-remitting multiple sclerosis's MeSH tree code is recorded as C10.314.350.500.600^[6].
• relapsing-remitting multiple sclerosis's MeSH tree code is recorded as C20.111.258.250.500.600^[7].
• relapsing-remitting multiple sclerosis's Disease Ontology ID is recorded as DOID:2378^[8].
• relapsing-remitting multiple sclerosis's Encyclopædia Britannica Online ID is recorded as topic/relapsing-remitting-multiple-sclerosis^[9].
• relapsing-remitting multiple sclerosis's NCI Thesaurus ID is recorded as C165675^[10].
• relapsing-remitting multiple sclerosis's health specialty is recorded as immunology^[11].
• relapsing-remitting multiple sclerosis's health specialty is recorded as neurology^[12].
• relapsing-remitting multiple sclerosis's drug or therapy used for treatment is recorded as teriflunomide^[13].
• relapsing-remitting multiple sclerosis's drug or therapy used for treatment is recorded as fingolimod^[14].
• relapsing-remitting multiple sclerosis's drug or therapy used for treatment is recorded as alemtuzumab^[15].
• relapsing-remitting multiple sclerosis's drug or therapy used for treatment is recorded as dalfampridine^[16].
• relapsing-remitting multiple sclerosis's drug or therapy used for treatment is recorded as interferon beta-1b^[17].
• relapsing-remitting multiple sclerosis's drug or therapy used for treatment is recorded as interferon beta-1a^[18].
• relapsing-remitting multiple sclerosis's drug or therapy used for treatment is recorded as daclizumab^[19].
• relapsing-remitting multiple sclerosis's drug or therapy used for treatment is recorded as natalizumab^[20].
• relapsing-remitting multiple sclerosis's drug or therapy used for treatment is recorded as methylprednisolone^[21].
• relapsing-remitting multiple sclerosis's drug or therapy used for treatment is recorded as dimethyl fumarate^[22].
• relapsing-remitting multiple sclerosis's exact match is recorded as http://purl.obolibrary.org/obo/DOID_2378^[23].
• relapsing-remitting multiple sclerosis's exact match is recorded as http://identifiers.org/doid/DOID:2378^[24].
• relapsing-remitting multiple sclerosis's UMLS CUI is recorded as C0751967^[25].
• relapsing-remitting multiple sclerosis's UMLS CUI is recorded as C0393664^[26].